REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors

Clinical trial NCT06710548 · RECRUITING

Trial details

NCT number: NCT06710548
Sponsor: Dana-Farber Cancer Institute
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Ovarian Cancer Advanced Ovarian Carcinoma Fallopian Tube Carcinoma Primary Peritoneal Cancer PARP Inhibitor Fatigue Related to Cancer Treatment Fatigue in Cancer Survivors

Start date: 2025-03-17
Primary completion: 2028-12-31
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.